XML 27 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash Flows From Operating Activities:  
Net income (loss)$ 40,236$ (53,284)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:  
Amortization of deferred revenue(9,225)(10,117)
Depreciation and amortization3,9913,320
Stock-based compensation15,2166,267
Change in fair value of common stock warrant liability3,488(6,030)
Fair value of common stock issued in connection with asset acquisition 1,661
Provision for bad debt189 
Loss on disposal of assets31 
Changes in operating assets and liabilities:  
Accounts receivable, net(26,904)(807)
Inventories, net(6,051)(565)
Prepaid expenses and other assets316(277)
Accounts payable and other accrued obligations6,3509,516
Accrued compensation and related expenses325(804)
Accrued drug development costs4,460406
Landlord contributions to tenant improvements 995
Deferred revenue and other credits(97)16,896
Net cash provided by (used in) operating activities32,325(32,823)
Cash Flows From Investing Activities:  
Maturities of marketable securities22,156 
Purchases of marketable securities(21,968)(4,097)
Purchases of property and equipment(380)(1,396)
Purchases of available for sale securities(164) 
Net cash used in investing activities(356)(5,493)
Cash Flows From Financing Activities:  
Proceeds from issuance of common stock from stock option exercises2,3881,082
Proceeds from issuance of common stock from warrant exercises24,808 
Proceeds from contributions to ESPP434306
Payments to acquire treasury stock(2,840) 
Repayment of capital leases(23)(21)
Net cash provided by financing activities24,7671,367
Net increase (decrease) in cash and cash equivalents56,736(36,949)
Cash and cash equivalents--beginning of period53,55782,336
Cash and cash equivalents--end of period110,29345,387
Supplemental Disclosure of Cash Flow Information:  
Conversion of preferred stock to common stock37 
Common stock issued for Targent milestones11,778 
Targent milestones included in intangible assets and accrued liabilities$ 5,000